What does the acquisition of AllCells by Discovery Life Sciences mean for my ongoing projects at Discovery and / or AllCells? | Discovery Life Sciences

Colorectal and Lung Tumoroids are Now Available NEW Blog Post - Progressing Ex Vivo Gene Editing Innovations with High-Quality Leukopaks NEW Blog Post - Improving Pathology Precision in Oncology: How AI Reduces Variability in Tumor Percent Assignments Discovery Announces Upcoming Launch of Tumoroids at Precision Med Tri-Con

Colorectal and Lung Tumoroids are Now Available NEW Blog Post - Progressing Ex Vivo Gene Editing Innovations with High-Quality Leukopaks NEW Blog Post - Improving Pathology Precision in Oncology: How AI Reduces Variability in Tumor Percent Assignments Discovery Announces Upcoming Launch of Tumoroids at Precision Med Tri-Con

AllCells’ scientists will remain part of Discovery, and all ongoing studies will continue to be serviced by those same dedicated experts. The flow of projects and timelines will be unaffected by the acquisition.

Privacy Settings